Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanatorium Kilchberg provides inpatient and outpatient care for adults with mental health conditions. It specializes in evidence-based therapies for stress-related illnesses such as burnout/exhaustion depression using its proprietary SymBalance program. The clinic also treats depression, anxiety/OCD, bipolar disorder, geriatric psychiatry issues including dementia assessments, eating disorders, sleep problems and psychosomatic pain. Its SymBalance concept has been scientifically evaluated.
No clinical trial results or drug pipeline—focus on patient outcomes from integrated psychotherapeutic programs.
English-language programs available since August 2024.
Collaborates with Selbsthilfe Zürich on self-help initiatives.
Key leadership includes Prof. Dr. med. Katja Cattapan (Medical Director).
Over 150 years old—one of Switzerland’s oldest private psychiatric clinics.
Not involved in pharmaceutical R&D or product commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanatorium Kilchberg.